This drug has one hundred and forty-three patent family members in thirty countries.
The generic ingredient in LEVEMIR FLEXPEN is insulin detemir recombinant. Three suppliers are listed for this compound. Additional details are available on the insulin detemir recombinant profile page.
Copyright © DrugPatentWatch. Originally published at New patent for Novo Nordisk drug LEVEMIR FLEXPEN